![](/images/graphics-bg.png)
Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”
Joint Authors
López-Morales, Carlos A.
Miranda-Hernández, Mariana P.
Perdomo-Abúndez, Francisco C.
Revilla-Beltri, Jorge
Salazar-Flores, Rodolfo D.
Ramírez-Ibanez, Nancy D.
Molina-Pérez, Aaron
Pérez, Néstor O.
Medina-Rivero, Emilio
Flores-Ortiz, Luis F.
Source
Journal of Immunology Research
Issue
Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2018-02-21
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
This communication responds to the Letter to the Editor [1], where noticeably Messrs.
Brian Hassett, Steven Vicik, and Brian Fitzpatrick from Pfizer Biotech contended that a particular glycan profile, presented in comparison to different profiles, does not correspond to the historical profile of the reference medicinal product of etanercept (Enbrel®), as it is exposed.
American Psychological Association (APA)
Miranda-Hernández, Mariana P.& López-Morales, Carlos A.& Perdomo-Abúndez, Francisco C.& Salazar-Flores, Rodolfo D.& Ramírez-Ibanez, Nancy D.& Pérez, Néstor O.…[et al.]. 2018. Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”. Journal of Immunology Research،Vol. 2018, no. 2018, pp.1-3.
https://search.emarefa.net/detail/BIM-1192699
Modern Language Association (MLA)
Miranda-Hernández, Mariana P.…[et al.]. Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”. Journal of Immunology Research No. 2018 (2018), pp.1-3.
https://search.emarefa.net/detail/BIM-1192699
American Medical Association (AMA)
Miranda-Hernández, Mariana P.& López-Morales, Carlos A.& Perdomo-Abúndez, Francisco C.& Salazar-Flores, Rodolfo D.& Ramírez-Ibanez, Nancy D.& Pérez, Néstor O.…[et al.]. Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”. Journal of Immunology Research. 2018. Vol. 2018, no. 2018, pp.1-3.
https://search.emarefa.net/detail/BIM-1192699
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1192699